-
Thu05Sep2024Sat07Sep2024
-
Fri06Sep2024
-
Fri13Sep2024Sat14Sep2024St. John's, Newfoundland and Labrador, Canada
-
Sat14Sep2024Wed18Sep2024
-
Thu19Sep2024Sun22Sep2024Charleston, South Carolina, United States
-
Thu19Sep2024Sun22Sep2024
-
Tue24Sep2024Fri27Sep2024
-
Thu26Sep2024Fri27Sep2024
Latest News
First patients treated in US GPS study of Paradise renal denervation...
The first patients in the USA have been treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS), a real-world study...
Features
Towards a clinically applicable prediction model for aneurysm shrinkage after EVAR
Michel Reijnen and Rianne van Rijswijk (both Rijnstate Hospital, Arnhem, The Netherlands) write about a new consortium focused on sac regression after endovascular aneurysm...
Vascular News’ top 10 most popular stories of June 2024
The top 10 most-read Vascular News stories in June featured two US Food and Drug Administration (FDA) investigational device exemption (IDE) approvals, Boston Scientific's...
Videos
CX co-chairs Dittmar Bӧckler (University Hospital Heidelberg, Heidelberg, Germany) and Andrew Holden (Auckland City Hospital, Auckland, New Zealand) discuss with Marc Schermerhorn (Beth Israel Deaconess Medical Center, Boston, USA) the unmet need in EVAR and the failure of some...
